Centre Leon Berard
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
1
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 22, 2027The maintenance fee for Use of FUBP1 Inhibitors for Treating Hepatitis B Virus Infection (US 11,732,262) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
- 1 fee due Apr 30, 2027The maintenance fee for Therapy Apparatus for Treating Tissue by the Emission of Remote Crossed Focused Ultrasound Waves (US 11,801,400) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 1 fee due May 26, 2027The maintenance fee for Shear Wave Generation Method, Shear Wave Imaging Method and Thermal Mapping or Treating Method Utilizing Such a Generation Method and Installation for Generating at Least One Shear Wave (US 10,485,516) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Jul 14, 2027The maintenance fee for ANTI-CK8 Antibodies for Use in the Treatment of Colorectal Cancers (US 10,533,046) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Antibodies Directed Against ICOS and Uses Thereof (US 10,633,446) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,203,641 | Screening for Anti-Cancer Compounds Using NETRIN-1 Activity In force · Medium confidence | In force | Medium confidence | |
| US 9,676,852 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,975,950 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,633,446 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,745,482 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,376,493 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,004,888 | Method for Determining Optimized Parameters of a Device Generating a Plurality of Ultrasound Beams Focused in a Region of Interest In force · High confidence | In force | High confidence | |
| US 11,180,556 | Antibodies Directed Against ICOS and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,895,439 | Combined Treatment with Netrin-1 Interfering Drug and Chemotherapeutic Drug In force · High confidence | In force | High confidence | |
| US 10,533,046 | ANTI-CK8 Antibodies for Use in the Treatment of Colorectal Cancers In force · High confidence | In force | High confidence |
Also on record, not counted in the 26: 13 patents in force now held by others · 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
21 pending · 20 abandoned · 1 no status recorded